US 6,395,767

Application 09/788,173 · Granted May 28, 2002

Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method

Estimated expiration

February 16, 2021

Expired 2104 days ago

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Feb 16, 2001
+ 20 years
Feb 16, 2021
PTA +0d
Feb 16, 2021
No TD
—
Final
Feb 16, 2021

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
February 16, 2001
Earliest effective filing
February 16, 2001
Issue date
May 28, 2002
PTA
0 days
Base expiry (before PTA)
February 16, 2021

February 16, 2001 + 20 years = February 16, 2021

  • PRO60/188,555 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 09/788,173 · US 6,395,767

PatentReply compiles the prosecution history behind US 6,395,767: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US6395767

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.